- Home
- NVCT vs XOMA Comparison
NVCT vs XOMA Comparison
Compare NVCT & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- XOMA
- Stock Information
- Founded
- NVCT 2020
- XOMA 1981
- Country
- NVCT United States
- XOMA United States
- Employees
- NVCT N/A
- XOMA N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- NVCT Health Care
- XOMA Health Care
- Exchange
- NVCT Nasdaq
- XOMA Nasdaq
- Market Cap
- NVCT 249.1M
- XOMA 294.2M
- IPO Year
- NVCT 2022
- XOMA N/A
- Fundamental
- Price
- NVCT $8.99
- XOMA $24.19
- Analyst Decision
- NVCT Strong Buy
- XOMA Strong Buy
- Analyst Count
- NVCT 3
- XOMA 2
- Target Price
- NVCT $17.00
- XOMA $69.50
- AVG Volume (30 Days)
- NVCT 157.3K
- XOMA 18.1K
- Earning Date
- NVCT 05-06-2025
- XOMA 05-20-2025
- Dividend Yield
- NVCT N/A
- XOMA N/A
- EPS Growth
- NVCT N/A
- XOMA N/A
- EPS
- NVCT N/A
- XOMA N/A
- Revenue
- NVCT N/A
- XOMA $28,487,000.00
- Revenue This Year
- NVCT N/A
- XOMA $17.89
- Revenue Next Year
- NVCT N/A
- XOMA $34.58
- P/E Ratio
- NVCT N/A
- XOMA N/A
- Revenue Growth
- NVCT N/A
- XOMA 498.72
- 52 Week Low
- NVCT $4.44
- XOMA $18.35
- 52 Week High
- NVCT $11.80
- XOMA $35.00
- Technical
- Relative Strength Index (RSI)
- NVCT 47.46
- XOMA 59.61
- Support Level
- NVCT $8.01
- XOMA $22.91
- Resistance Level
- NVCT $9.62
- XOMA $25.17
- Average True Range (ATR)
- NVCT 1.04
- XOMA 1.15
- MACD
- NVCT -0.16
- XOMA 0.07
- Stochastic Oscillator
- NVCT 27.96
- XOMA 69.28
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.